The Use of Heparin for Treating Human Malignancies
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
There is a substantial amount of data implicating coagulation mechanisms in the pathogenesis of malignancy. Studies in some experimental animal models have shown that the anticoagulant heparin limits tumour growth and metastasis and prolongs survival. Experience with the effects of heparin on human malignancy is limited primarily to settings in which it was given either to prevent or to treat thrombosis in patients who also had cancer. However, these studies have shown noteworthy apparent improvement in cancer outcome with heparin, especially with low-molecular-weight heparin. There are several possible mechanisms by which heparin could potentially alter the natural history of cancer progression because of its ability to modify the cellular and molecular environment of tumour cells. This experience provides the rationale for definitive clinical trials of heparin in patients with cancer and also for further experimentation to define the mechanisms of antineoplastic activity by this familiar class of drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Smeal, T., Binetruy, B., Mercola, D. A., Birrer, M., & Karin, M. (1991) · Nature · doi:10.1038/354494a0 · Cited by 789
Calcium-Dependent Heparin-Like Ligands For L-Selectin in Nonlymphoid Endothelial Cells
Norgard-Sumnicht, K. E., Varki, N. M., & Varki, A. (1993) · Science · doi:10.1126/science.7687382 · Cited by 197
Enhancement of mixed leukocyte reaction and cytotoxic antitumor responses by heparin
Dziarski, R. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.1.356 · Cited by 26
Cited by
Borsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061615598 · Cited by 714
Borsig, L., Wong, R., Hynes, R. O., Varki, N. M., & Varki, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261704098 · Cited by 400
Deadly allies: the fatal interplay between platelets and metastasizing cancer cells
Erpenbeck, L., & Schön, M. P. (2010) · Blood · doi:10.1182/blood-2009-10-247296 · Cited by 345
Selectin Blocking Activity of a Fucosylated Chondroitin Sulfate Glycosaminoglycan from Sea Cucumber
Borsig, L., Wang, L., Cavalcante, M. C. M., Cardilo-Reis, L., Ferreira, P. L., Mourąo, P. A. S., Esko, J. D., & Pavąo, M. S. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610560200 · Cited by 187
Metadata
- Authors
- Ornstein, D. L., & Zacharski, L. R.
- Venue
- Pathophysiology of Haemostasis and Thrombosis
- Publisher
- S. Karger AG
- Published
- 1999
- Volume
- 29
- Issue
- Suppl. 1
- Pages
- 48-60
- ISSN
- 1424-8832 (ISSN-L)
- 1424-8840
- OpenAlex
- W2089787588
- Cited by
- 43
- References
- 4
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.